© Springer-Verlag 2011
Published: 11 September 2011
The Italian Society for the Study of Headaches (SISC) announces the competition of the biennial Enrico Greppi Award 2012. The award will be granted to the best unpublished original paper dealing with clinical, epidemiological, genetic, pathophysiological or therapeutic aspects of headache. The prize amounts to 10,000 € and is open to researchers of all nationalities. The papers must be submitted in accordance with the editorial instructions of The Journal of Headache and Pain. The winning article will be published ex officio in The Journal of Headache and Pain within 3 months of the Award presentation. The remaining papers are considered as submitted to The Journal of Headache and Pain and may be published after undergoing the peer-reviewing process. The Award is endorsed by the European Headache Federation (EHF) and the winner is invited to present the paper at the third European Headache and Migraine Trust International Congress 2012 (EHMTIC), to be held in London, UK on 20–23 September 2012.
Manuscripts should be sent by e-mail to the President of SISC at email@example.com no later than 25 June 2012.
Rules for the Enrico Greppi Award
The Italian Society for the Study of Headaches sponsors an Award in memory of Enrico Greppi, pioneer and expert in the study of headache.
The Award is assigned every 2 years to an unpublished paper dealing with clinical, epidemiological, genetic, pathophysiological or therapeutic aspects of headache. Competing papers must be written in accordance with the editorial instructions of The Journal of Headache and Pain which can be found at http://www.springer.com/10194. Papers submitted for the Enrico Greppi Award should be sent by e-mail to firstname.lastname@example.org and not submitted via Editorial Manager.
There is no limit of age for participants of the Enrico Greppi Award.
All researchers in the headache field may compete for the Award. Members of both SISC and EHF Boards of Directors may compete as well, if they are not serving on the Selection Committee and did not participate in the nomination of the Selection Committee.
The Award winner is invited to present his/her paper as the “Enrico Greppi Award Lecture” at the third EHMTIC.
The Award is of 10,000 €, which will be received during the third EHMTIC, along with a certificate signed by all members of the Selection Committee.
The competition will be announced in the EHF official journal, The Journal of Headache and Pain, and in other scientific journals. Within 3 months of the announcement of the Award, The Journal of Headache and Pain will publish ex offìcio the winning manuscript, including the list of members of the Selection Committee. The remaining papers are considered submitted to The Journal of Headache and Pain and may be published after undergoing the peer-reviewing process.
The Selection Committee will be composed of the SISC President as chairman, an EHF representative, the Editor-in-Chief of The Journal of Headache and Pain, one member of the SISC Board of Directors and two members chosen from international experts in the headache field. The Committee is nominated by the SISC Board of Directors. Should the SISC President not be able to chair, the oldest member of the Committee will assume his role. The papers will be judged by each Committee member individually on a scale from 0 to 10. Each Committee member is responsible for sending his scores to the President of the Committee. The scores of at least four Committee members are necessary to determine the winner. The winning paper must receive an average score of not <6. In the case of a tie, the President’s vote will have a double value. Should a tie persist, there will be a random drawing in the presence of a notary. No Award will be assigned if less than four judges send their scores or if no paper receives a score of at least 6. In this case, the Award amount will be deposited in the prize funds.
The competing manuscripts must be e-mailed to the SISC President at email@example.com no later than 25 June 2012.
The Award has been partly supported through unrestricted educational grants by the Italian Patients Headache Alliance (LIC) and Pfizer S.r.l.